Home / News
-
-
Invitae said recently that it will acquire Clear Genetics, a developer of software that supports the delivery of genetics services at scale, for approximately $50 million.2019-12-02View More
-
-
Expedeon announced recently that it has agreed to sell its immunology and proteomics businesses to UK-based life science reagents and tools company Abcam for €120 million ($130.0 million) in cash.2019-12-02View More
-
-
Castle Biosciences reported after the close of the market recently that its third quarter revenues skyrocketed 300 percent year over year due to growth in the firm's DecisionDx- Melanoma test report volume.2019-12-02View More
-
-
Liquid biopsy firm Lexent Bio recently announced a non-exclusive partnership with Illumina to develop an in vitro diagnostic kit for cancer.2019-12-02View More
-
-
Danaher announced Wednesday that its wholly owned subsidiary DH Europe Finance has priced its offering of $3.97 billion senior notes.2019-10-31View More
-
-
Waters posted revenues of $577.3 million in Q3 compared to $578.0 million in Q3 2018 and falling short of the average Wall Street estimate of $588.9 million.2019-10-31View More
-
-
The Stratum Foot Plating System is the next generation of anatomic locking plates designed to optimize ease of use and reduce operating time.2019-10-31View More
-
-
A new study from the University of South Australia researchers found the number of people that die from bowel or colorectal cancer (CRC) would be much higher without pre-diagnostic colonoscopies.2019-10-31View More
-
-
Qiagen and Illumina just made a huge commitment to one another. The two companies announced a 15-year partnership to broaden the availability and use of NGS-based in-vitro diagnostic kits, including companion diagnostics, for patient management.2019-10-31View More
-
-
Researchers from the University of Strathclyde have developed a blood test that could help to accelerate the diagnosis of brain cancer.2019-10-31View More
-
-
Roche has won a nod from FDA for a new diagnostic for individual blood donation testing. The Basel-Switzerland-based company¡¯s cobas Babesia test is for use on the cobas 6800 8800 system.2019-10-31View More
-
-
In diagnostics these days, ¡°a lot of people are after plasma,¡± reports Jim Averso, vice president, sales and marketing, of I.W. Tremont.2019-10-31View More
-
-
Bio-Techne said recently that its fiscal 2020 first quarter revenues rose 12 percent year over year, driven by growth in each of its business segments.2019-10-31View More
-
-
The National Institutes of Health has awarded researchers at the University of Virginia a $2.7 million grant to investigate how variation in a specific gene, called ID3, influences atherosclerosis.2019-10-31View More
-
-
Genialis recently announced a comarketing agreement with Thermo Fisher Scientific on data analysis for RNA sequencing.2019-10-31View More
-
-
Exact Sciences reported after the close of the market recently that its third quarter revenues rose 85 percent year over year, thanks to an 89 percent increase in testing volumes for its Cologuard colorectal cancer screening test.2019-10-31View More
-
-
LexaGene said recently that it has closed a previously announced financing round, grossing C$6.7 million (US$5.1 million).2019-10-31View More
-
-
Korean rare disease diagnostics firm 3billion said this week that it has raised $10 million in a Series B financing round.2019-10-31View More
-
-
Illumina and Qiagen recently announced a 15-year partnership to develop next-generation sequencing-based in vitro diagnostic kits, including companion diagnostics.2019-10-31View More
-
-
Genomic services provider Novogene has signed an agreement to develop a companion diagnostic for a cancer drug under development at Chipscreen Biosciences, the Chinese companies said today.2019-10-31View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.